Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 21, 2018

DrugPatentWatch Database Preview

Novel Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?

NOVEL LABS INC has fifty-five approved drugs.

There are two tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc

US Patents:	0
Tradenames:	44
Ingredients:	42
NDAs:	55

Drugs and US Patents for Novel Labs Inc

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, CHEWABLE;ORAL	204115-001	Feb 25, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	204407-003	Feb 24, 2017	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	LEVONORGESTREL	levonorgestrel	TABLET;ORAL	202508-001	Feb 22, 2013		OTC	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	CALCIPOTRIENE	calcipotriene	SOLUTION;TOPICAL	207163-001	Dec 26, 2017	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow

Chinese Patent Office

Colorcon

McKesson

Accenture

Cantor Fitzgerald

McKinsey

Julphar

Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.